Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Longchao Liu

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|March 4, 2016
Clearing Persistent Extracellular Antigen of Hepatitis B Virus: An Immunomodulatory Strategy To Reverse Tolerance for an Effective Therapeutic VaccinationDanming Zhu, Longchao Liu, Dan Yang, et al.
JCI Insight|April 10, 2020
Targeting tumors with IL-21 reshapes the tumor microenvironment by proliferating PD-1intTim-3-CD8+ T cellsSisi Deng, Zhichen Sun, Jian Qiao, et al.
Cell Reports|August 23, 2018
Dual Targeting of Innate and Adaptive Checkpoints on Tumor Cells Limits Immune EvasionXiaojuan Liu, Longchao Liu, Zhenhua Ren, et al.
Nature Cell Biology|December 6, 2022
IL-2 delivery by engineered mesenchymal stem cells re-invigorates CD8<sup>+</sup> T cells to overcome immunotherapy resistance in cancerJoonbeom Bae, Longchao Liu, Casey Moore, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 23, 2026
Identifying Cytokine Motif-Containing, Immunomodulatory Bacterial Proteins in Human Gut MicrobiomeZiyu Wang, Siqi Guo, Jing Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 14, 2019
Investigation of Antigen-Specific T-Cell Receptor Clusters in Human CancersHongyi Zhang, Longchao Liu, Jian Zhang, et al.
Hepatology (Baltimore, Md.)|April 27, 2017
Vaccines targeting preS1 domain overcome immune tolerance in hepatitis B virus carrier miceYingjie Bian, Zheng Zhang, Zhichen Sun, et al.
Science Immunology|August 11, 2019
Hypofractionated EGFR tyrosine kinase inhibitor limits tumor relapse through triggering innate and adaptive immunityZhida Liu, Chuanhui Han, Chunbo Dong, et al.
Scientific Reports|November 25, 2025
Human level information extraction from clinical reports with finetuned language modelsLongchao Liu, Long Lian, Yiyan Hao, et al.
Cancer Cell|December 18, 2020
DNA Sensing in Mismatch Repair-Deficient Tumor Cells Is Essential for Anti-tumor ImmunityChangzheng Lu, Junhong Guan, Steve Lu, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Journal of Immunology (Baltimore, Md. : 1950)|March 4, 2016
Clearing Persistent Extracellular Antigen of Hepatitis B Virus: An Immunomodulatory Strategy To Reverse Tolerance for an Effective Therapeutic VaccinationDanming Zhu, Longchao Liu, Dan Yang, et al.
JCI Insight|April 10, 2020
Targeting tumors with IL-21 reshapes the tumor microenvironment by proliferating PD-1intTim-3-CD8+ T cellsSisi Deng, Zhichen Sun, Jian Qiao, et al.
Cell Reports|August 23, 2018
Dual Targeting of Innate and Adaptive Checkpoints on Tumor Cells Limits Immune EvasionXiaojuan Liu, Longchao Liu, Zhenhua Ren, et al.
Nature Cell Biology|December 6, 2022
IL-2 delivery by engineered mesenchymal stem cells re-invigorates CD8<sup>+</sup> T cells to overcome immunotherapy resistance in cancerJoonbeom Bae, Longchao Liu, Casey Moore, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 23, 2026
Identifying Cytokine Motif-Containing, Immunomodulatory Bacterial Proteins in Human Gut MicrobiomeZiyu Wang, Siqi Guo, Jing Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 14, 2019
Investigation of Antigen-Specific T-Cell Receptor Clusters in Human CancersHongyi Zhang, Longchao Liu, Jian Zhang, et al.
Hepatology (Baltimore, Md.)|April 27, 2017
Vaccines targeting preS1 domain overcome immune tolerance in hepatitis B virus carrier miceYingjie Bian, Zheng Zhang, Zhichen Sun, et al.
Science Immunology|August 11, 2019
Hypofractionated EGFR tyrosine kinase inhibitor limits tumor relapse through triggering innate and adaptive immunityZhida Liu, Chuanhui Han, Chunbo Dong, et al.
Scientific Reports|November 25, 2025
Human level information extraction from clinical reports with finetuned language modelsLongchao Liu, Long Lian, Yiyan Hao, et al.
Cancer Cell|December 18, 2020
DNA Sensing in Mismatch Repair-Deficient Tumor Cells Is Essential for Anti-tumor ImmunityChangzheng Lu, Junhong Guan, Steve Lu, et al.
Pageof 3